Gene · 962
Papers3,378
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
241 to 260 of 3,378
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| KRAS G12V neoantigen specific T cell receptor for adoptive T cell therapy against tumors. | Nat Commun | 2023 | 37828002 | PubTator, text mining | PubMed |
| Don't eat me/eat me signals as a novel strategy in cancer immunotherapy. | Heliyon | 2023 | 37822610 | PubTator, text mining | PubMed |
| A SARS-CoV-2 related signature that explores the tumor microenvironment and predicts immunotherapy response in esophageal squamous cell cancer. | Aging (Albany NY) | 2023 | 37812215 | PubTator, text mining | PubMed |
| Distinct and targetable role of calcium-sensing receptor in leukaemia. | Nat Commun | 2023 | 37802982 | PubTator, text mining | PubMed |
| Gastric cancer metastasis-related NT5DC2 indicates unfavorable prognosis of patients. | Medicine (Baltimore) | 2023 | 37800836 | PubTator, text mining | PubMed |
| Identification of two immune subtypes and four hub immune-related genes in ovarian cancer through multiple analysis. | Medicine (Baltimore) | 2023 | 37800814 | PubTator, text mining | PubMed |
| Identification of disulfidptosis-related subgroups and prognostic signatures in lung adenocarcinoma using machine learning and experimental validation. | Front Immunol | 2023 | 37799714 | PubTator, text mining | PubMed |
| An "off-the-shelf" CD2 universal CAR-T therapy for T-cell malignancies. | Leukemia | 2023 | 37798328 | PubTator, text mining | PubMed |
| The integrated single-cell analysis developed an immunogenic cell death signature to predict lung adenocarcinoma prognosis and immunotherapy. | Aging (Albany NY) | 2023 | 37796202 | PubTator, text mining | PubMed |
| Independent prognostic biomarker FERMT3 associated with immune infiltration and immunotherapy response in glioma. | Ann Med | 2023 | 37795794 | PubTator, text mining | PubMed |
| Identification of lactate regulation pattern on tumor immune infiltration, therapy response, and DNA methylation in diffuse large B-cell lymphoma. | Front Immunol | 2023 | 37790933 | PubTator, text mining | PubMed |
| RAD51AP1 as an Immune-Related Prognostic Biomarker and Therapeutic Response Predictor in Hepatocellular Carcinoma. | Int J Gen Med | 2023 | 37789880 | PubTator, text mining | PubMed |
| A blinded in vitro analysis of the intrinsic immunogenicity of hepatotoxic drugs: implications for preclinical risk assessment. | Toxicol Sci | 2023 | 37788119 | PubTator, text mining | PubMed |
| Acute motor-sensory axonal polyneuropathy variant of Guillain-Barré syndrome with a thalamic lesion and COVID-19: a case report and discussion on mechanism. | Front Neurol | 2023 | 37780717 | PubTator, text mining | PubMed |
| Identification of Tumor Antigens and Immune Subtypes of High-grade Serous Ovarian Cancer for mRNA Vaccine Development. | J Cancer | 2023 | 37779866 | PubTator, text mining | PubMed |
| Barcoding intracellular reverse transcription enables high-throughput phenotype-coupled T cell receptor analyses. | Cell Rep Methods | 2023 | 37776855 | PubTator, text mining | PubMed |
| A multimodal radiomic machine learning approach to predict the LCK expression and clinical prognosis in high-grade serous ovarian cancer. | Sci Rep | 2023 | 37773310 | PubTator, text mining | PubMed |
| A novel signature for predicting prognosis and immune landscape in cutaneous melanoma based on anoikis-related long non-coding RNAs. | Sci Rep | 2023 | 37770477 | PubTator, text mining | PubMed |
| Disseminated Mycobacterium genavense Infection Mimicking Sarcoidosis: A Case Report and Review of Literature on Japanese Patients. | Microorganisms | 2023 | 37763989 | PubTator, text mining | PubMed |
| The Comparison of Serum Exosome Protein Profile in Diagnosis of NSCLC Patients. | Int J Mol Sci | 2023 | 37761972 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/962/papers?page=13